Search research articles
Contact Us
Filters
Showing results (111-120 of 176) with videos related to
Page
of 18
Sort By:
Cancer
|
March 13, 2016
Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting
Jennifer L Steel, David A Geller, Kevin H Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)
Lisa H Butterfield, Fengmin Zhao, Sandra Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2015
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)
David H Lawson, Sandra Lee, Fengmin Zhao, et al.
European Urology
|
December 24, 2014
A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802
Robert S DiPaola, Yu-Hui Chen, Glenn J Bubley, et al.
Journal for Immunotherapy of Cancer
|
September 4, 2021
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR
Nicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, et al.
Molecular Therapy. Methods & Clinical Development
|
November 1, 2017
Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus
Zong Sheng Guo, Zuqiang Liu, Magesh Sathaiah, et al.
Journal for Immunotherapy of Cancer
|
November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations
Kevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
Giuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2016
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule
Howard L Kaufman, Lisa H Butterfield, Pierre G Coulie, et al.
JCI Insight
|
April 6, 2018
Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomas
Sören Müller, Sameer Agnihotri, Karsen E Shoger, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 176) with videos related to
Sort By:
Page
of 18
Cancer
|
March 13, 2016
Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting
Jennifer L Steel, David A Geller, Kevin H Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)
Lisa H Butterfield, Fengmin Zhao, Sandra Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2015
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)
David H Lawson, Sandra Lee, Fengmin Zhao, et al.
European Urology
|
December 24, 2014
A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802
Robert S DiPaola, Yu-Hui Chen, Glenn J Bubley, et al.
Journal for Immunotherapy of Cancer
|
September 4, 2021
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR
Nicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, et al.
Molecular Therapy. Methods & Clinical Development
|
November 1, 2017
Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus
Zong Sheng Guo, Zuqiang Liu, Magesh Sathaiah, et al.
Journal for Immunotherapy of Cancer
|
November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations
Kevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
Giuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2016
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule
Howard L Kaufman, Lisa H Butterfield, Pierre G Coulie, et al.
JCI Insight
|
April 6, 2018
Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomas
Sören Müller, Sameer Agnihotri, Karsen E Shoger, et al.
Page
of 18